We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Non-Invasive Gut Tests Could Help Diagnose Inflammatory Bowel Disease and Colon Cancer

By LabMedica International staff writers
Posted on 15 Feb 2024
Print article
Image: Mucus contains vital data to help address inflammatory bowel disease and colon cancer (Photo courtesy of 123RF)
Image: Mucus contains vital data to help address inflammatory bowel disease and colon cancer (Photo courtesy of 123RF)

New research is set to simplify and make gut health monitoring less invasive by focusing on an often-ignored yet readily available source: the mucus in our digestive tract that ultimately becomes part of fecal matter.

Researchers at UBC Okanagan (Kelowna, BC, Canada) have developed a method to analyze vital gut health markers from fecal-adherent mucus, essentially the mucus that adheres to stool. This mucus, typically discarded in stool, is actually rich in data about gut health. The team has pioneered a non-invasive approach to study MUC2, a key protein found in the stool that plays a significant role in gut health. MUC2 is a glycoprotein with numerous sugar chains that creates a protective mucus barrier in the intestines. This barrier is essential for defending the gut against harmful microbes and toxins and is integral to digestive health.

Previously, it was believed that this crucial molecule could only be extracted through invasive and painful methods like biopsies or surgical tissue removal. However, this study has revealed that mucus is a natural component of human stool, meaning it can be painlessly obtained and at levels not possible before at any time and that too non-invasively. A deeper understanding of MUC2 could pave the way for breakthroughs in the treatment and prevention of gut-related diseases, potentially improving the daily health of millions.

“MUC2 is like the silent star in our guts. It’s constantly working to protect us, and its proper functioning is crucial for our overall health,” said researcher Dr. Kirk Bergstrom. “We can use these new methods to visualize mucus-microbiota interactions and how they go wrong in various diseases, like inflammatory bowel diseases and colon cancer.”

Related Links:
UBC Okanagan

Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Gold Member
ZIKA Virus Test
ZIKA ELISA IgG
New
Coccidioidomycosis Test
Premier Coccidioides Antibody Test

Print article

Channels

Hematology

view channel
Image: The new test could improve specialist transplant and transfusion practice as well as blood banking (Photo courtesy of NHS Blood and Transplant)

New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape

The release of oxygen by red blood cells is a critical process for oxygenating the body's tissues, including organs and muscles, particularly in individuals receiving large blood transfusions.... Read more

Immunology

view channel
Image: Concept for the device. Memory B cells able to bind influenza virus remain stuck to channels despite shear forces (Photo courtesy of Steven George/UC Davis)

Microfluidic Chip-Based Device to Measure Viral Immunity

Each winter, a new variant of influenza emerges, posing a challenge for immunity. People who have previously been infected or vaccinated against the flu may have some level of protection, but how well... Read more

Microbiology

view channel
Image: The iFAST reader scans 5000 individual bacteria with each sample analyzed in less than a minute (Photo courtesy of iFAST)

High-Throughput AST System Uses Microchip Technology to Rapidly Analyze Bacterial Samples

Bacteria are becoming increasingly resistant to antibiotics, with resistance levels ranging from 20% to 98%, and these levels are unpredictable. Currently, antimicrobial susceptibility testing (AST) takes... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.